tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Gilead Sciences (GILD)
NASDAQ:GILD
US Market
GILD
Gilead Sciences
Overview
Analyst Forecasts
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Gilead Sciences (GILD) Stock News & Sentiment

Compare
13,090 Followers
Gilead Sciences: Strong Momentum and Promising Future with New HIV Drug Launch Justifies Buy Rating
Premium
Ratings
Gilead Sciences: Strong Momentum and Promising Future with New HIV Drug Launch Justifies Buy Rating
22h ago
GILD
QQQ ETF News, 3/3/2025
Premium
Market News
QQQ ETF News, 3/3/2025
1d ago
AEP
AMD
Optimistic Buy Rating for Gilead Sciences Driven by Anticipated FDA Approval and Strategic Market Positioning
Premium
Ratings
Optimistic Buy Rating for Gilead Sciences Driven by Anticipated FDA Approval and Strategic Market Positioning
8d ago
GILD
Gilead Sciences: Buy Rating Backed by Strong Q4 Performance, Strategic Initiatives, and Promising Pipeline
Premium
Ratings
Gilead Sciences: Buy Rating Backed by Strong Q4 Performance, Strategic Initiatives, and Promising Pipeline
11d ago
GILD
Buy Recommendation for Gilead Sciences: Promising Outlook with Seladelpar Approval and Robust Drug Portfolio
Premium
Ratings
Buy Recommendation for Gilead Sciences: Promising Outlook with Seladelpar Approval and Robust Drug Portfolio
15d ago
GILD
Gilead Sciences: Strong Financial Performance and Promising Future Prospects Drive Optimistic Outlook
Premium
Ratings
Gilead Sciences: Strong Financial Performance and Promising Future Prospects Drive Optimistic Outlook
19d ago
GILD
Gilead Sciences: Strong Performance and Growth Potential in HIV and Oncology Segments Boost Buy Rating
Premium
Ratings
Gilead Sciences: Strong Performance and Growth Potential in HIV and Oncology Segments Boost Buy Rating
19d ago
GILD
More GILD News >

GILD News on the Web

Gilead Sciences Rises As Market Takes a Dip: Key Facts
Yahoo Finance
Neutral
Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts
Zacks
Bullish
Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug
Zacks
Neutral
KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease Drug
Zacks
Neutral
Apellis Q4 Loss Narrower Than Expected, Syfovre Sales Drive Revenues
Zacks
Bullish
Novartis Gets CHMP Opinion for Label Expansion of Fabhalta
Zacks
Neutral
Where to go as stock market gains slow, according to Goldman Sachs
CNBC
Neutral
Bullish On GILD? You Might Want To Consider This Credit Put Spread Expiring in 15 Days
Market Chameleon
Bullish

News Score - Last 7 Days

Very Positive
GILD
Sector Average
Media Buzz
This Week31 articles
Weekly Average33 articles
News Sentiment
This Week100%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GILD’s Media Buzz Sentiment?
31 articles about GILD were published this week. In an average week, 33 articles are published.
    What is GILD’s weekly average amount of articles?
    In an average week, 33 articles about GILD are published.
      What is GILD’s News Sentiment?
      100% of articles about GILD were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        CCCCC4 Therapeutics
        JAZZJazz Pharmaceuticals
        CTECConvaTec
        CORTCorcept Therapeutics
        RCKTRocket Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing